| Year |
Citation |
Score |
| 2016 |
Menchón JM, van Ameringen M, Dell'Osso B, Denys D, Figee M, Grant JE, Hollander E, Marazziti D, Nicolini H, Pallanti S, Ruck C, Shavitt R, Stein DJ, Andersson E, Bipeta R, et al. Standards of care for obsessive-compulsive disorder centres. International Journal of Psychiatry in Clinical Practice. 20: 204-208. PMID 27359333 DOI: 10.1080/13651501.2016.1197275 |
1 |
|
| 2016 |
Pallanti S, Marras A, Salerno L, Makris N, Hollander E. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. Journal of Psychopharmacology (Oxford, England). PMID 26843373 DOI: 10.1177/0269881116628427 |
1 |
|
| 2015 |
Grant JE, Fineberg N, van Ameringen M, Cath D, Visser H, Carmi L, Pallanti S, Hollander E, van Balkom AJ. New treatment models for compulsive disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26621260 DOI: 10.1016/j.euroneuro.2015.11.008 |
1 |
|
| 2015 |
Shic F, Smith D, Horsburgh B, Hollander E, Rehg JM, Goodwin M. Catalysts for Change: The Role of Small Business Funders in the Creation and Dissemination of Innovation. Journal of Autism and Developmental Disorders. PMID 26481385 DOI: 10.1007/s10803-015-2636-x |
1 |
|
| 2015 |
Dell'Osso B, Nicolini H, Lanzagorta N, Benatti B, Spagnolin G, Palazzo MC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, et al. Cigarette smoking in patients with obsessive compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-5. PMID 26349811 DOI: 10.1017/S1092852915000565 |
1 |
|
| 2015 |
Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals. Psychological Science. 26: 1177-86. PMID 26122122 DOI: 10.1177/0956797615580279 |
1 |
|
| 2015 |
Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, Daskalakis ZJ, Winston JL, Dannon P, Hafez HM, Reti IM, Morales OG, Schlaepfer TE, Hollander E, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 64-73. PMID 25655160 DOI: 10.1002/wps.20199 |
1 |
|
| 2014 |
Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, Cuzen NL, Hollander E, Denys D, Nicolini H, Dell'Osso B, Pallanti S, Stein DJ. Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Comprehensive Psychiatry. 55: 1513-9. PMID 25011690 DOI: 10.1016/j.comppsych.2014.05.020 |
1 |
|
| 2014 |
Van Ameringen M, Simpson W, Patterson B, Dell'Osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H, Pallanti S, Stein DJ, et al. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Journal of Psychopharmacology (Oxford, England). 28: 596-602. PMID 24429223 DOI: 10.1177/0269881113517955 |
1 |
|
| 2014 |
Berlin GS, Hollander E. Compulsivity, impulsivity, and the DSM-5 process Cns Spectrums. 19: 62-68. PMID 24229702 DOI: 10.1017/S1092852913000722 |
1 |
|
| 2014 |
Hirota T, Veenstra-Vanderweele J, Hollander E, Kishi T. Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. Journal of Autism and Developmental Disorders. 44: 948-57. PMID 24077782 DOI: 10.1007/s10803-013-1952-2 |
1 |
|
| 2013 |
King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. Jama Pediatrics. 167: 1045-52. PMID 24061784 DOI: 10.1001/jamapediatrics.2013.2698 |
1 |
|
| 2013 |
Doyle-Thomas KA, Duerden EG, Taylor MJ, Lerch JP, Soorya LV, Wang AT, Fan J, Hollander E, Anagnostou E. Effects of age and symptomatology on cortical thickness in autism spectrum disorders. Research in Autism Spectrum Disorders. 7: 141-150. PMID 23678367 DOI: 10.1016/j.rasd.2012.08.004 |
1 |
|
| 2013 |
Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/s10803-013-1775-1 |
1 |
|
| 2013 |
Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E. A double-blind, placebo-controlled trial of topiramate for pathological gambling. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 121-8. PMID 21486110 DOI: 10.3109/15622975.2011.560964 |
1 |
|
| 2012 |
Anagnostou E, Soorya L, Chaplin W, Bartz J, Halpern D, Wasserman S, Wang AT, Pepa L, Tanel N, Kushki A, Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Molecular Autism. 3: 16. PMID 23216716 DOI: 10.1186/2040-2392-3-16 |
1 |
|
| 2012 |
Fan J, Bernardi S, Van Dam NT, Anagnostou E, Gu X, Martin L, Park Y, Liu X, Kolevzon A, Soorya L, Grodberg D, Hollander E, Hof PR. Functional deficits of the attentional networks in autism. Brain and Behavior. 2: 647-60. PMID 23139910 DOI: 10.1002/brb3.90 |
1 |
|
| 2012 |
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. International Journal of Psychiatry in Clinical Practice. 16: 77-84. PMID 22540422 DOI: 10.3109/13651501.2012.667114 |
1 |
|
| 2012 |
Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. The American Journal of Psychiatry. 169: 292-9. PMID 22193531 DOI: 10.1176/appi.ajp.2011.10050764 |
1 |
|
| 2012 |
Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, et al. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 42: 432-40. PMID 21667200 DOI: 10.1007/s10803-011-1251-8 |
1 |
|
| 2011 |
Ameis SH, Fan J, Rockel C, Voineskos AN, Lobaugh NJ, Soorya L, Wang AT, Hollander E, Anagnostou E. Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study. Plos One. 6: e28044. PMID 22132206 DOI: 10.1371/journal.pone.0028044 |
1 |
|
| 2011 |
Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, Pepa L, Kolevzon A, Abi-Dargham A, Laruelle M, Hollander E. The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB. Psychiatry Research. 194: 230-4. PMID 22079057 DOI: 10.1016/j.pscychresns.2011.04.007 |
1 |
|
| 2011 |
Hankin CS, Koran L, Sheehan DV, Hollander E, Culpepper L, Black DW, Knispel J, Dunn J, Dougherty DD, Bronstone A, Wang Z. Patients with obsessive-compulsive disorder vs depression have comparable health care costs: a retrospective claims analysis of Florida Medicaid enrollees. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 23: 285-96. PMID 22073386 |
1 |
|
| 2011 |
Anagnostou E, Chaplin W, Watner D, Silverman JM, Smith CJ, Zagursky K, Kryzak LA, Corwin TE, Feirsen N, Tanel N, Hollander E. Factor analysis of repetitive behaviors in Autism as measured by the Y-BOCS. The Journal of Neuropsychiatry and Clinical Neurosciences. 23: 332-9. PMID 21948895 DOI: 10.1176/appi.neuropsych.23.3.332 |
1 |
|
| 2011 |
Hildebrandt T, Langenbucher JW, Lai JK, Loeb KL, Hollander E. Development and validation of the appearance and performance enhancing drug use schedule. Addictive Behaviors. 36: 949-58. PMID 21640487 DOI: 10.1016/j.addbeh.2011.05.002 |
1 |
|
| 2011 |
Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, Hof PR, Fan J. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Research. 1380: 198-205. PMID 21185269 DOI: 10.1016/j.brainres.2010.12.057 |
1 |
|
| 2011 |
Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Social Cognitive and Affective Neuroscience. 6: 556-63. PMID 21115541 DOI: 10.1093/scan/nsq085 |
1 |
|
| 2011 |
Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 72: 716-21. PMID 20816027 DOI: 10.4088/JCP.09m05266gre |
1 |
|
| 2010 |
Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A, Ochsner KN. Oxytocin selectively improves empathic accuracy. Psychological Science. 21: 1426-8. PMID 20855907 DOI: 10.1177/0956797610383439 |
1 |
|
| 2010 |
Pallanti S, Haznedar MM, Hollander E, Licalzi EM, Bernardi S, Newmark R, Buchsbaum MS. Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. Neuropsychobiology. 62: 132-8. PMID 20588072 DOI: 10.1159/000317286 |
1 |
|
| 2010 |
Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depression and Anxiety. 27: 528-55. PMID 20533367 DOI: 10.1002/da.20705 |
1 |
|
| 2010 |
Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. The Journal of Clinical Psychiatry. 71: 784-92. PMID 20492845 DOI: 10.4088/JCP.09m05911blu |
1 |
|
| 2010 |
Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depression and Anxiety. 27: 507-27. PMID 20217853 DOI: 10.1002/da.20669 |
1 |
|
| 2010 |
Kolevzon A, Newcorn JH, Kryzak L, Chaplin W, Watner D, Hollander E, Smith CJ, Cook EH, Silverman JM. Relationship between whole blood serotonin and repetitive behaviors in autism. Psychiatry Research. 175: 274-6. PMID 20044143 DOI: 10.1016/j.psychres.2009.02.008 |
1 |
|
| 2010 |
Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 990-8. PMID 20010551 DOI: 10.1038/npp.2009.202 |
1 |
|
| 2010 |
Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 591-604. PMID 19940844 DOI: 10.1038/npp.2009.185 |
1 |
|
| 2009 |
Hankin CS, Koran LM, Bronstone A, Black DW, Sheehan DV, Hollander E, Dunn JD, Culpepper L, Knispel J, Dougherty DD, Wang Z. Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder. Cns Spectrums. 14: 695-703. PMID 20394177 |
1 |
|
| 2009 |
Stein DJ, Denys D, Gloster AT, Hollander E, Leckman JF, Rauch SL, Phillips KA. Obsessive-compulsive disorder: diagnostic and treatment issues. The Psychiatric Clinics of North America. 32: 665-85. PMID 19716996 DOI: 10.1016/j.psc.2009.05.007 |
1 |
|
| 2009 |
King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry. 66: 583-90. PMID 19487623 DOI: 10.1001/archgenpsychiatry.2009.30 |
1 |
|
| 2009 |
Smith CJ, Lang CM, Kryzak L, Reichenberg A, Hollander E, Silverman JM. Familial associations of intense preoccupations, an empirical factor of the restricted, repetitive behaviors and interests domain of autism. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 50: 982-90. PMID 19298470 DOI: 10.1111/j.1469-7610.2009.02060.x |
1 |
|
| 2008 |
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 9: 248-312. PMID 18949648 DOI: 10.1080/15622970802465807 |
1 |
|
| 2008 |
Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 58: 37-47. PMID 18781089 DOI: 10.1159/000154478 |
1 |
|
| 2008 |
Berlin HA, Hamilton H, Hollander E. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. The Mount Sinai Journal of Medicine, New York. 75: 174-203. PMID 18704978 DOI: 10.1002/msj.20045 |
1 |
|
| 2008 |
Bartz JA, Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders Progress in Brain Research. 170: 451-462. PMID 18655901 DOI: 10.1016/S0079-6123(08)00435-4 |
1 |
|
| 2008 |
Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology. 18: 157-78. PMID 18439113 DOI: 10.1089/cap.2007.0041 |
0.36 |
|
| 2008 |
Gotham K, Risi S, Dawson G, Tager-Flusberg H, Joseph R, Carter A, Hepburn S, McMahon W, Rodier P, Hyman SL, Sigman M, Rogers S, Landa R, Spence MA, Osann K, ... ... Hollander E, et al. A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. Journal of the American Academy of Child and Adolescent Psychiatry. 47: 642-51. PMID 18434924 DOI: 10.1097/CHI.0b013e31816bffb7 |
1 |
|
| 2008 |
Trivedi MH, Hollander E, Nutt D, Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression Journal of Clinical Psychiatry. 69: 246-258. PMID 18363453 |
1 |
|
| 2008 |
Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. The Journal of Clinical Psychiatry. 69: 452-6. PMID 18312057 |
1 |
|
| 2008 |
Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Baker BR, Greenberg JL, Hollander E. An open-label trial of venlafaxine in body dysmorphic disorder. Cns Spectrums. 13: 138-44. PMID 18227745 |
1 |
|
| 2007 |
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 61: 498-503. PMID 16904652 DOI: 10.1016/j.biopsych.2006.05.030 |
1 |
|
| 2006 |
Bartz JA, Hollander E. The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Hormones and Behavior. 50: 518-28. PMID 16884725 DOI: 10.1016/j.yhbeh.2006.06.018 |
1 |
|
| 2006 |
Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30: 338-352. PMID 16455175 DOI: 10.1016/j.pnpbp.2005.11.003 |
1 |
|
| Show low-probability matches. |